Role of HSCT in children and adolescents with refractory or relapsed NHL

被引:0
|
作者
Burkhardt, Birgit [1 ]
Pillon, Marta [2 ]
Taj, Mary [3 ]
Garnier, Nathalie [4 ]
Minard, Veronique [5 ]
Hazar, Volkan [6 ,7 ,8 ]
Mellgren, Karin [9 ]
Osumi, Tomoo [10 ]
Fedorova, Alina [11 ]
Myakova, Natalia [12 ]
Verdu-Amoros, Jaime [13 ]
Andres, Mara [14 ]
Kabickova, Edita [15 ,16 ]
Attarbaschi, Andishe [17 ]
Chiang, Alan [18 ]
Bubanska, Eva [19 ,20 ]
Donska, Svetlana [21 ]
Hjalgrim, Lisa L. [22 ]
Wachowiak, Jacek [23 ]
Pieczonka, Anna [23 ]
Uyttebroeck, Anne [24 ]
Loeffen, Jan [25 ]
Buechner, Jochen [26 ]
Niggli, Felix [27 ]
Palma, Julia [28 ]
Burke, Amos [29 ]
Beishuizen, Auke [25 ]
Koeppen, Kristin [1 ]
Herbrueggen, Heidi [1 ]
Woessmann, Wilhelm [30 ]
Zimmermann, Martin [31 ]
Balduzzi, Adriana [32 ]
机构
[1] Univ Hosp Muenster, Dept Pediat Hematol Oncol & BMT, Munster, Germany
[2] Univ Hosp Padua, Dept Child & Woman Hlth, Div Hematol Oncol, Padua, Italy
[3] Royal Marsden Hosp, Dept Paediat Oncol, Sutton, Surrey, England
[4] Hosp Civils Lyon, Inst Pediat Hematol & Oncol, Lyon, France
[5] Gustave Roussy Canc Campus, Dept Pediat Oncol, Villejuif, France
[6] Med Pk Goztepe Hosp, Dept Pediat Hematol, Istanbul, Turkey
[7] Med Pk Goztepe Hosp, Dept Oncol, Istanbul, Turkey
[8] Med Pk Goztepe Hosp, BMT Unit, Istanbul, Turkey
[9] Queen Silvia Childrens Hosp, Dept Pediat Oncol & Hematol, Sahlgrenska Univ Hosp, Gothenburg, Sweden
[10] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Tokyo, Japan
[11] Belarusian Res Ctr Pediat Oncol Hematol & Immunol, Dept Clin Res, Minsk, BELARUS
[12] Fed Ctr Pediat Hematol Oncol & Immunol, Pediat Hematol & Oncol, Moscow, Russia
[13] Univ Hosp Valencia, Dept Pediat Hematol & Oncol, Valencia, Spain
[14] Univ Hosp Le Fe, Dept Pediat Oncol, Valencia, Spain
[15] Charles Univ Prague, Prague, Czech Republic
[16] Univ Hosp Motol, Dept Paediat Haematol & Oncol, Prague, Czech Republic
[17] Med Univ Vienna, St Anna Childrens Hosp, Dept Pediat Hematol & Oncol, Vienna, Austria
[18] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China
[19] Slovak Hlth Univ, Banska Bystrica, Slovakia
[20] Childrens Fac Hosp, Clin Pediat Oncol & Hematol, Banska Bystrica, Slovakia
[21] Natl Ukrainian Childrens Hosp Ochmatdyt, Ctr Pediat Oncohematol & BMT, Kiev, Ukraine
[22] Dept Paediat & Adolescent Med, Copenhagen, Denmark
[23] Poznan Univ Med Sci, Dept Pediat Oncol Hematol & Transplantol, Poznan, Poland
[24] Univ Hosp Gasthuisberg, Dept Paediat Haematol & Oncol, Leuven, Belgium
[25] Sophia Childrens Univ Hosp, Erasmus Med Ctr Rotterdam, Dept Pediat Oncol & Hematol, Rotterdam, Netherlands
[26] Oslo Univ Hosp, Dept Pediat Hematol & Oncol, Oslo, Norway
[27] Univ Childrens Hosp Zurich, Dept Pediat Oncol, Zurich, Switzerland
[28] Univ Chile, Fac Med, Hosp Luis Calvo Mackenna, Dept Pediat,Bone Marrow Transplantat Unit, Santiago, Chile
[29] Addenbrookes Hosp, Cambridge Univ Hosp NHS Fdn Trust, Dept Paediat Haematol & Oncol & Palliat Care, Cambridge, England
[30] Justus Liebig Univ, Dept Pediat Hematol & Oncol, Giessen, Germany
[31] Hannover Med Sch, Dept Pediat Hematol & Oncol, Hannover, Germany
[32] Univ Milano Bicocca, San Gerardo Hosp, Clin Pediat Univ Milano Bicocca, Monza, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
30
引用
收藏
页码:24 / 24
页数:1
相关论文
共 50 条
  • [21] Venetoclax (VEN) in patients with relapsed/refractory non-Hodgkin lymphoma (NHL).
    Davids, Matthew Steven
    Roberts, Andrew Warwick
    Seymour, John Francis
    Wierda, William G.
    Puvvada, Soham D.
    Gressick, Lori A.
    Alter, Debbie
    Zhou, Lang
    Kim, Su Young
    Verdugo, Maria
    Gerecitano, John F.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] Are two monoclonal antibodies more effective than a single in the relapsed or refractory NHL?
    Choquet, Sylvain
    HEMATOLOGIE, 2005, 11 (05): : 302 - 302
  • [23] Venetoclax (VEN) in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma (NHL).
    Davids, M.
    Roberts, A.
    Seymour, J.
    Wierda, W.
    Puvvada, S.
    Gressick, L.
    Alter, D.
    Zhou, L.
    Kim, S.
    Verdugo, M.
    Gerecitano, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 74 - 74
  • [24] OUTCOMES OF SALVAGE CHEMOTHERAPY REGIMENS IN CHILDREN AND ADOLESCENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
    Tak, Himangi
    Trivedi, Maharshi
    Joshi, Nitin
    Panchal, Harsha
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S553 - S553
  • [25] Functional Imaging in Children and Adolescents with Relapsed or Refractory Hodgkin Lymphoma and Outcome after Autologous Transplantation
    Ozuah, Nmazuo
    Dahmoush, Hisham
    Grant, Frederick
    Lehmann, Leslie
    Billett, Amy
    Margossian, Steven P.
    BLOOD, 2016, 128 (22)
  • [26] Comprehensive Characterization of Tumor Immune Microenvironment in Children and Adolescents with Relapsed or Refractory Cancers: The Immunoacts Project
    Pasqualini, C.
    Marchais, A.
    Rondof, W.
    Scoazec, J. Y.
    Minard-Colin, V.
    Labaied, N.
    Lacroix, L.
    Pierron, G.
    Adam-De-Beaumais, T.
    Lapouble, E.
    Berlanga, P.
    Waterfall, J.
    Delattre, O.
    Valteau-Couanet, D.
    Schleiermacher, G.
    Vassal, G.
    Geoerger, B.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S71 - S71
  • [27] Mitoxantrone in Combination with Clofarabine (MITCL) in Children, Adolescents and Young Adults with Refractory/Relapsed Acute Leukemia
    Hochberg, Jessica C.
    Oesterheld, Javier
    Flower, Allyson M.
    Klejmont, Liana
    Hemenway, Gregory
    Harrison, Lauren
    Shi, Qiuhu
    Cairo, Mitchell S.
    BLOOD, 2017, 130
  • [28] TANDEM AUTOLOGOUS ALLOGENEIC STEM CELL TRANSPLANTATION IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH RELAPSED/REFRACTORY MATURE B-CELL NON-HODGKIN LYMPHOMA (B-NHL)
    Gardenswartz, A.
    Mehta, B.
    El-Mallawany, N.
    van de Ven, C.
    Hochberg, J.
    Flower, A.
    Morris, E.
    Harrison, L.
    Basso, J.
    Gerard, P.
    Ayello, J.
    Baxter-Lowe, L. A.
    Cairo, M. S.
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [29] Conditioning with treosulfan and fludarabine for patients with refractory or relapsed non-Hodgkin lymphoma (NHL)
    Schmitt, M.
    Sayer, H. G.
    Hilgendorf, I
    Treschl, A.
    Junghanss, C.
    Borchert, K.
    Koenigsmann, M.
    Casper, J.
    Freund, M.
    Kahl, C.
    ONKOLOGIE, 2010, 33 : 164 - 164
  • [30] Long-term outcomes of older patients with relapsed/refractory NHL referred to ASCT
    Pytlik, Robert
    Vackova, Blanka
    Konirova, Eva
    Trnkova, Marie
    Blahovcova, Petra
    Pohlreich, David
    Polgarova, Kamila
    Klener, Pavel, Jr.
    Benesova, Katerina
    Kopeckova, Katerina
    Pirnos, Jan
    Trneny, Marek
    BONE MARROW TRANSPLANTATION, 2021, 56 (03) : 709 - 712